US Endoscopy announces full market release of the Infinity™ sampling device
Mentor, Ohio - October 25, 2011 - US Endoscopy, a world leader in endoscopy device design and manufacturing, is proud to announce the release of the Infinity™ sampling device. This device is purpose-built for collecting substantial and quality samples from strictures in the biliary duct during ERCP (endoscopic retrograde cholangiopancreatography) procedures.
"Numerous physicians are asking for a device that can deliver higher yield samples during ERCP," says Gulam Khan, US Endoscopy CEO, President, and Co-chairman. "Current methods do not always provide sufficient cell collection, causing frustration and difficulty in making an accurate diagnosis. We have designed the Infinity™ device to help physicians obtain a higher yield sample, providing the information needed for a more definitive diagnosis."
The Infinity™ sampling device features a combination bristle design. The stiff bristles help create a defect in the tissue of the biliary duct while the soft bristles capture the abraded material. This unique collection method is designed to produce a higher yield and cellular sample.
About US Endoscopy
Since 1991, US Endoscopy has been a world leader in endoscopy device design and manufacturing, serving the U.S. and international gastrointestinal endoscopy markets. By listening and delivering solutions in the field of endoscopy, our unique lines of proprietary devices provide better, more enhanced product options for GI clinicians. A significant and growing portion of sales are proprietary endoscopic devices created by the company's new product development team with the guidance and direction of luminary physicians and nurses worldwide.
US Endoscopy press releases can be found in the News section of www.usendoscopy.com . To arrange interviews concerning US Endoscopy products and services, please Contact Us.